This rapid diagnostic nasopharyngeal test detects evidence of antigens (toxins) produced by the virus. Approved by FDA under Emergency Use Act as a diagnostic test. Well suited for general business and personal testing. If using this test for travel, always check the embassy website of the country you’re traveling to for the most up to date requirements. For additional questions, you may visit our FAQ page at https://www.arcpointlabs.com/covid19-faqs. This test requires a nasopharyngeal nasal swab.